Evolent Health [EVH] vs Teladoc Health [TDOC] Detailed Stock Comparison
Evolent Health
NYSE
Loading...
Teladoc Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Evolent Health wins in 11 metrics, Teladoc Health wins in 7 metrics, with 0 ties. Evolent Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Evolent Health | Teladoc Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -10.16 | -1.50 | Evolent Health |
| Price-to-Book Ratio | 1.06 | 1.12 | Evolent Health |
| Debt-to-Equity Ratio | 75.85 | 72.78 | Teladoc Health |
| PEG Ratio | -0.02 | 0.02 | Evolent Health |
| EV/EBITDA | 26.10 | 103.14 | Evolent Health |
| Profit Margin (TTM) | -5.94% | -8.16% | Evolent Health |
| Operating Margin (TTM) | 0.64% | -7.29% | Evolent Health |
| EBITDA Margin (TTM) | 0.64% | N/A | N/A |
| Return on Equity | -11.04% | -14.18% | Evolent Health |
| Return on Assets (TTM) | -0.21% | -3.57% | Evolent Health |
| Free Cash Flow (TTM) | $-6.13M | $169.63M | Teladoc Health |
| 1-Year Return | -69.51% | -6.85% | Teladoc Health |
| Price-to-Sales Ratio (TTM) | 0.43 | 0.63 | Evolent Health |
| Enterprise Value | $1.89B | $1.95B | Teladoc Health |
| EV/Revenue Ratio | 0.86 | 0.77 | Teladoc Health |
| Gross Profit Margin (TTM) | 22.59% | 69.85% | Teladoc Health |
| Revenue per Share (TTM) | $19 | $15 | Evolent Health |
| Earnings per Share (Diluted) | $-1.60 | $-1.15 | Teladoc Health |
| Beta (Stock Volatility) | 0.66 | 1.91 | Evolent Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Evolent Health vs Teladoc Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Evolent Health | 0.24% | -5.93% | -14.68% | -29.12% | -12.23% | -28.20% |
| Teladoc Health | -4.88% | 4.51% | 9.31% | 6.20% | 18.53% | -9.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Evolent Health | -69.51% | -73.47% | -27.18% | -49.82% | -56.26% | -56.26% |
| Teladoc Health | -6.85% | -63.00% | -96.13% | -52.39% | -69.39% | -69.39% |
News Based Sentiment: Evolent Health vs Teladoc Health
Evolent Health
News based Sentiment: NEGATIVE
October was a significantly negative month for Evolent Health, with a substantial earnings miss, revenue decline, and a sharp drop in share price. While some analysts maintain a positive outlook, the overall narrative points to increased risk and uncertainty for investors, making it a crucial period for the company to demonstrate a turnaround.
Teladoc Health
News based Sentiment: MIXED
October was a month of conflicting signals for Teladoc, with continued financial challenges offset by a surprising stock surge and strategic initiatives. The regulatory environment remains a key risk, creating a mixed outlook for investors. The combination of positive market reaction and underlying financial concerns makes this a significant month for the company.
Performance & Financial Health Analysis: Evolent Health vs Teladoc Health
| Metric | EVH | TDOC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.06B | $1.59B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,100,400 | 8,888,160 |
| 90 Day Avg. Volume | 3,139,787 | 5,961,557 |
| Last Close | $8.25 | $8.57 |
| 52 Week Range | $7.06 - $27.42 | $6.35 - $15.21 |
| % from 52W High | -69.91% | -43.66% |
| All-Time High | $39.78 (Sep 12, 2022) | $308.00 (Feb 15, 2021) |
| % from All-Time High | -79.26% | -97.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.31% | -0.02% |
| Quarterly Earnings Growth | N/A | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | -0.08% |
| Operating Margin (TTM) | 0.01% | -0.07% |
| Return on Equity (TTM) | -0.11% | -0.14% |
| Debt to Equity (MRQ) | 75.85 | 72.78 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.73 | $8.05 |
| Cash per Share (MRQ) | $1.30 | $3.85 |
| Operating Cash Flow (TTM) | $-33,330,000 | $303.43M |
| Levered Free Cash Flow (TTM) | $-77,390,624 | $209.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Evolent Health vs Teladoc Health
| Metric | EVH | TDOC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -10.16 | -1.50 |
| Forward P/E | 5.76 | -10.12 |
| PEG Ratio | -0.02 | 0.02 |
| Price to Sales (TTM) | 0.43 | 0.63 |
| Price to Book (MRQ) | 1.06 | 1.12 |
| Market Capitalization | ||
| Market Capitalization | $1.06B | $1.59B |
| Enterprise Value | $1.89B | $1.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.86 | 0.77 |
| Enterprise to EBITDA | 26.10 | 103.14 |
| Risk & Other Metrics | ||
| Beta | 0.66 | 1.91 |
| Book Value per Share (MRQ) | $7.73 | $8.05 |
Financial Statements Comparison: Evolent Health vs Teladoc Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EVH | TDOC |
|---|---|---|
| Revenue/Sales | $483.65M | $629.37M |
| Cost of Goods Sold | $381.18M | $196.83M |
| Gross Profit | $102.47M | $432.54M |
| Research & Development | N/A | $69.96M |
| Operating Income (EBIT) | $4,000 | $-54.94M |
| EBITDA | $25.27M | $50.34M |
| Pre-Tax Income | $-63.15M | $-111.27M |
| Income Tax | $1.47M | $-18.26M |
| Net Income (Profit) | $-64.62M | $-93.01M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EVH | TDOC |
|---|---|---|
| Cash & Equivalents | $246.55M | $679.62M |
| Total Current Assets | $727.93M | $1.07B |
| Total Current Liabilities | $739.10M | $401.77M |
| Long-Term Debt | $663.12M | $1.03B |
| Total Shareholders Equity | $935.52M | $1.42B |
| Retained Earnings | $-845.44M | $-16.36B |
| Property, Plant & Equipment | $5.73M | $27.67M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EVH | TDOC |
|---|---|---|
| Operating Cash Flow | $-23.39M | $89.56M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-4.03M | $31.63M |
| Debt Repayment | $-62.50M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EVH | TDOC |
|---|---|---|
| Shares Short | 23.10M | 23.82M |
| Short Ratio | 7.22 | 5.40 |
| Short % of Float | 0.20% | 0.15% |
| Average Daily Volume (10 Day) | 3,100,400 | 8,888,160 |
| Average Daily Volume (90 Day) | 3,139,787 | 5,961,557 |
| Shares Outstanding | 115.04M | 173.41M |
| Float Shares | 91.32M | 174.74M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.09% | 0.74% |
Dividend Analysis & Yield Comparison: Evolent Health vs Teladoc Health
| Metric | EVH | TDOC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |